PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...
One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...
Avita Health System’s renovations on a $15 million, 22,000-square-foot comprehensive cancer center at Avita South Campus are ...
The Allan Labor Government is investing in world-class health technology in Melbourne's north, getting locals the care they need faster and closer to ...
APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and a presentation by Dr.
Niagara Falls, NY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical ...
Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback